Advertisement

Ads Placeholder
Loading...

TriSalus Life Sciences, Inc.

TLSI•NASDAQ
Healthcare
Medical - Devices
$4.24
$0.06(1.44%)
U.S. Market opens in 20h 28m

TriSalus Life Sciences, Inc. (TLSI) Stock Overview

Explore TriSalus Life Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap160.7M
P/E Ratio-5.06
EPS (TTM)$-1.84
ROE1.37%
Fundamental Analysis

AI Price Forecasts

1 Month$4.28
3 Months$4.37
1 Year Target$4.45

TLSI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of TriSalus Life Sciences, Inc. (TLSI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.24, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.45.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.06 and a market capitalization of 160.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.44%
5-Day Change
10.13%
1-Month Change
-14.17%
3-Month Change
-30.49%
6-Month Change
-8.23%
Year-to-Date (YTD) Change
-30.49%
1-Year Change
-18.77%
3-Year Change
-58.79%
5-Year Change
-57.04%
All-Time (Max) Change
-59.70%

Contact Information

https://trisaluslifesci.com
888 321 5212
6272 West 91st Avenue, Westminster, CO, 80031

Company Facts

1,100 Employees
IPO DateFeb 8, 2021
CountryUS
Actively Trading

Frequently Asked Questions